What the labels and official product information report
Labels use clinical words. Flatulence means passing gas. Abdominal distension means the belly feels full or stretched and may look bigger. Both sit in the adverse reactions section, either in the main table or in a list of other stomach reactions that were more frequent than on placebo [1][6]. The patient Medication Guide for Wegovy® uses plainer terms, listing feeling bloated and gas among its most common side effects [1].
- Ranges reflect doses. In the Mounjaro® pool, flatulence rose from 1.3% on 5 mg to 2.9% on 15 mg, while distension went 0.4%, 2.9% and 0.8% without a tidy pattern [6].
- The Wegovy® tablet trial reported common reactions similar in type and frequency to the injection table, without separate gas figures [1].
- Teenagers: in the Saxenda® trial in 12 to 17 year olds, flatulence was reported by 3.2% on liraglutide and by no one on placebo [5].
- In Europe, flatulence and distension are in the common band for Wegovy®, and the Ozempic® leaflet lists bloating and gas as common, meaning up to 1 in 10 people [10][11].
- Rows come from different trials, people and durations, so comparing one medicine with another across rows says little. Belching (eructation) appears in the same tables and has its own article.
| Document and trial pool | Flatulence | Abdominal distension |
|---|---|---|
| Wegovy® 2.4 mg injection, US label: adult weight trials [1] | 4% → 6% | 5% → 7% |
| Wegovy® 7.2 mg injection, US label: Studies 8 and 9 [1] | 2% → 4% (2.4 mg arm 2%) | not in that table |
| Zepbound®, US label: Studies 1 and 2 [2] | 2% → 3–4% | 2% → 3–4% |
| Zepbound®, Canadian monograph: SURMOUNT-1 and -2 [3] | 1.6% → 3.2–4.0% | 2.2% → 3.4–4.0% |
| Foundayo™ daily tablet, US label: Trials 1 and 2 [4] | 2% → 5–6% | 3% → 7–9% |
| Saxenda®, US label: adult weight trials [5] | 2.5% → 4% | 3% → 4.5% |
| Mounjaro®, US label: type 2 diabetes placebo pool [6] | 0% → 1.3–2.9% | 0.4% → 0.4–2.9% |
| Ozempic® injection, US label: two type 2 diabetes trials [7] | 0.8% → 0.4–1.5% | not listed |
| Rybelsus® and Ozempic® tablets, US label: placebo pool [8] | 0% → 1–2% | 1% → 2–3% |
| Trulicity®, US label: type 2 diabetes placebo pool [9] | 1.4% → 1.4–3.4% | 0.7% → 2.3–2.9% |
What pooled studies add
Gas and bloating are rarely the focus of research, which tends to concentrate on nausea, vomiting, diarrhea and constipation. One 2023 meta-analysis pooled randomised trials of tirzepatide in type 2 diabetes. Compared with placebo, total stomach-related events, nausea, constipation and vomiting were clearly higher at every dose, but abdominal distension and abdominal pain were not significantly different [12]. The authors also reported that these events eased over time.
A meta-analysis of published trials is only as good as the reporting in those trials, and mild bloating is often recorded inconsistently. It does fit the label figures, where the gap between medicine and placebo for distension is usually a few percentage points [2][6].
Why gas and bloating may happen
- Supported by the labels: every one of these medicines delays stomach emptying [1][2][4]. For tirzepatide and orforglipron, the labels add that the delay is greatest after the first dose and lessens over time [2][4]. The labels do not tie this delay to flatulence or distension directly.
- Supported by the labels: stomach reactions cluster around dose increases. Wegovy® says so for distension and flatulence, and the EU information agrees [1][10].
- Proposed but not measured: constipation is one of the most common reactions on these medicines [1][2], and MedlinePlus lists treating constipation among the steps for bloating [15]. No study has tested how much GLP-1 bloating comes from constipation.
- General knowledge: gas comes from swallowed air and from gut bacteria breaking down carbohydrates that the small intestine did not absorb. Changes in what and how you eat can shift both [13].
Other causes worth ruling out
NIDDK lists several conditions that produce extra gas or make it more noticeable: irritable bowel syndrome and other functional gut disorders, lactose or fructose intolerance, small intestinal bacterial overgrowth, coeliac disease and reflux [13]. MedlinePlus adds visceral hypersensitivity, where the gut nerves are oversensitive, and some medicines and sweeteners, such as sorbitol and lactulose [15].
Less often, bloating comes from a blockage in the bowel or from conditions that need prompt investigation [13][15]. The labels say these medicines are not recommended for people with severe gastroparesis, and reports after approval include ileus and intestinal obstruction [1][2]. The gastroparesis article on this site covers that question.
What may ease gas and bloating
NIDDK describes ways to swallow less air: eat more slowly and sitting down, avoid talking while eating, and cut back on fizzy drinks, straws, chewing gum and hard sweets [14]. It also mentions smaller, more frequent meals and noticing which foods make symptoms worse; common examples include beans and lentils, broccoli and cabbage, foods high in fructose or lactose, and products sweetened with sugar alcohols [14].
A short food and symptom diary can help a clinician or dietitian look for patterns. Over-the-counter gas remedies exist; ask a pharmacist before using them, partly because GLP-1 medicines slow stomach emptying and can change how other tablets are absorbed [2]. NIDDK advises talking with a doctor before probiotics or supplements [14]. Do not change your GLP-1 dose or schedule on your own because of bloating.
Where brand detail and related symptoms are covered
Brand pages such as Wegovy® and bloating, Ozempic® and bloating and Zepbound® and bloating look at each label on its own. Burping, constipation and gastroparesis each have their own article.
Ozempic®, Wegovy®, Rybelsus® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound® and Trulicity® are registered trademarks of Eli Lilly and Company; Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Severe stomach pain that does not go away, with or without vomiting, sometimes felt in the back | Stop the medicine and call your provider right away | Emergency | Wegovy® and Zepbound® labels [1][2] |
| A swollen, painful belly with vomiting, or being unable to pass stool or gas | Emergency care | Emergency | Postmarketing reports in the labels [1][2]; NIDDK [13] |
| Pain in the upper belly, fever, yellow skin or eyes, or clay-coloured stools | Your prescriber | Today | Wegovy® Medication Guide [1] |
| Bloating or gas with blood in the stool, black stools, vomiting or weight loss you did not expect | A clinician | Today | MedlinePlus [15] |
| Gas or bloating that bothers you or does not settle | Your prescriber, pharmacist or a dietitian | At your next appointment | NIDDK [13][14] |
